10/6
08:20 am
lbrx
Rating for LBRX
Low
Report
Rating for LBRX
10/6
08:08 am
lbrx
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $34.00 price target on the stock.
Low
Report
LB Pharmaceuticals (NASDAQ:LBRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $34.00 price target on the stock.
10/6
07:27 am
lbrx
Rating for LBRX
Low
Report
Rating for LBRX
10/6
06:15 am
lbrx
LB Pharmaceuticals initiated with an Outperform at Leerink
Low
Report
LB Pharmaceuticals initiated with an Outperform at Leerink
10/6
05:15 am
lbrx
LB Pharmaceuticals initiated with a Buy at Stifel
Low
Report
LB Pharmaceuticals initiated with a Buy at Stifel